Last reviewed · How we verify
pegylated interferon
pegylated interferon is a Small molecule drug developed by Replicor Inc.. It is currently FDA-approved. Also known as: pegylated interferon alpha 2a, Pegasys(R), Pegasys, Pegylated interferon (PegIFN), Pegintron.
At a glance
| Generic name | pegylated interferon |
|---|---|
| Also known as | pegylated interferon alpha 2a, Pegasys(R), Pegasys, Pegylated interferon (PegIFN), Pegintron, PegIntron |
| Sponsor | Replicor Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients (NA)
- A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006) (PHASE3)
- Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma (PHASE2)
- A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV (NA)
- Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma (PHASE1)
- Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B (PHASE4)
- Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B (PHASE4)
- A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pegylated interferon CI brief — competitive landscape report
- pegylated interferon updates RSS · CI watch RSS
- Replicor Inc. portfolio CI
Frequently asked questions about pegylated interferon
What is pegylated interferon?
pegylated interferon is a Small molecule drug developed by Replicor Inc..
Who makes pegylated interferon?
pegylated interferon is developed and marketed by Replicor Inc. (see full Replicor Inc. pipeline at /company/replicor-inc).
Is pegylated interferon also known as anything else?
pegylated interferon is also known as pegylated interferon alpha 2a, Pegasys(R), Pegasys, Pegylated interferon (PegIFN), Pegintron, PegIntron.
What development phase is pegylated interferon in?
pegylated interferon is FDA-approved (marketed).
Related
- Manufacturer: Replicor Inc. — full pipeline
- Also known as: pegylated interferon alpha 2a, Pegasys(R), Pegasys, Pegylated interferon (PegIFN), Pegintron, PegIntron
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing